Amcor reports year to date results and raises outlook for fiscal 2021
NEWS PROVIDED BY
Amcor
May 04, 2021, 16:10 ET
ZURICH, May 4, 2021 /PRNewswire/ --
Highlights - Nine Months Ended March 31, 2021
Strong result and continued momentum drive increased guidance for Fiscal 2021
- GAAP Net Income of $684 million, up 58%; GAAP earnings per share (EPS) of 43.8 cents per share, up 63%;
- Adjusted EPS of 51.5 cents per share, up 16% on a comparable constant currency basis;
- Adjusted EBIT of $1,144 million, up 9% on a comparable constant currency basis;
- $55 million Bemis cost synergies year to date; expect approximately $70 million in FY21 and well positioned to deliver at least $180 million by end of fiscal 2022;
- Quarterly dividend higher than this quarter last year at 11.75 cents per share;
- Approximately 2% of outstanding shares repurchased year to date; and
- Fiscal 2021 outlook for adjusted EPS growth raised to 14-15% in constant currency terms (previously 10-14%).
Amcor's CEO Ron Delia said: "Amcor is maintaining momentum and executing well in the face of a dynamic operating environment. As a result, we delivered strong year-to-date performance and we are raising our full year adjusted EPS growth outlook to 14-15% in constant currency terms."
"The business delivered strong adjusted EBIT growth of 9% on a year to date basis and organic growth has continued to strengthen as we progress through the fiscal 2021 year. Delivery of cost synergies related to the Bemis acquisition continues to progress ahead of original expectations leaving us well positioned to exceed the original target with at least $180 million of pre-tax benefits by the end of fiscal 2022."
"Amcor has a clearly defined, consistent capital allocation framework which starts with strong annual Free Cash Flow in excess of $1 billion and growing. We are actively investing in the future, expanding capacity in higher value segments and higher growth markets and increasingly using open innovation and now corporate venturing to identify new avenues of growth. Growth investments like these, along with continued strong execution, will enable continued momentum and reinforce our belief that the Amcor investment case has never been stronger."
- Forums
- ASX - By Stock
- AMC
- Ann: Form 8-K - Q3 21 Results
Ann: Form 8-K - Q3 21 Results, page-8
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AMC (ASX) to my watchlist
|
|||||
Last
$14.40 |
Change
-0.070(0.48%) |
Mkt cap ! $8.605B |
Open | High | Low | Value | Volume |
$14.46 | $14.46 | $14.38 | $18.83M | 1.308M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 24624 | $14.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.42 | 2581 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 19765 | 14.400 |
1 | 103 | 14.390 |
3 | 4260 | 14.380 |
1 | 4536 | 14.370 |
2 | 3523 | 14.360 |
Price($) | Vol. | No. |
---|---|---|
14.420 | 2581 | 2 |
14.430 | 19765 | 1 |
14.440 | 1566 | 2 |
14.470 | 700 | 1 |
14.490 | 2207 | 3 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
AMC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online